3-(6-Bromo-pyridin-2-yloxy)-piperidine-1-carboxylicacidtert-butylester
97%
- Product Code: 152192
CAS:
1065484-39-0
Molecular Weight: | 357.243 g./mol | Molecular Formula: | C₁₅H₂₁BrN₂O₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD10698905 | |
Melting Point: | Boiling Point: | 416.4±45.0 °C(Predicted) | |
Density: | 1.355 g/cm3 | Storage Condition: | Room temperature, seal, dry |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the construction of complex heterocyclic systems important in drug discovery. Commonly employed in medicinal chemistry for modifying pyridine-based scaffolds to enhance binding affinity and selectivity toward target enzymes. Also utilized in research settings to prepare analogs for structure-activity relationship (SAR) studies.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.500 | 10-20 days | Ft207,356.85 |
+
-
|
3-(6-Bromo-pyridin-2-yloxy)-piperidine-1-carboxylicacidtert-butylester
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors and other bioactive molecules. Its structure supports the construction of complex heterocyclic systems important in drug discovery. Commonly employed in medicinal chemistry for modifying pyridine-based scaffolds to enhance binding affinity and selectivity toward target enzymes. Also utilized in research settings to prepare analogs for structure-activity relationship (SAR) studies.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
Ft0.00
Ft0.00
Total :